Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Epstein-Barr virus (EBV) deletions as biomarkers of response to treatment of chronic active EBV.

British journal of haematology - 1 Oct 2021

Venturini Cristina, Houldcroft Charlotte J, Lazareva Arina, Wegner Fanny, Morfopoulou Sofia, Amrolia Persis J, Golwala Zainab, Rao Anupama, Marks Stephen D, Simmonds Jacob, Yoshikawa Tetsushi, Farrell Paul J, Cohen Jeffrey I, Worth Austen J, Breuer Judith

Abstract excerpt

Chronic active Epstein-Barr virus (CAEBV) disease is a rare condition characterised by persistent EBV infection in previously healthy individuals. Defective EBV genomes were found in East Asian patients with CAEBV. In the present study, we sequenced 14 blood EBV samples from three UK patients with CAEBV, comparing the results with saliva CAEBV samples and other conditions. We observed EBV deletions in blood, some...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Asia, Eastern
Share to Chronic Disease

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Defective Viruses

Share to Epstein-Barr Virus Infections

Share to Herpesvirus 4, Human

Share to Immunologic Factors

Share to Rituximab

Share to Saliva

Source

Open in PubMed Open full text

Identifiers

PMID: 34431085
DOI: 10.1111/bjh.17790
PMCID: PMC8589012

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Epstein-Barr virus (EBV) deletions as biomarkers of response to treatment of chronic active EBV.PMID 34431085Read ↗

Oncogenesis of CAEBV revealed: Intragenic deletions in the viral genome and leaky expression of lytic genesSemantic proximity Read ↗

Rapid identification and characterization of infected cells in blood during chronic active Epstein-Barr virus infection.Semantic proximity Read ↗

Do Epstein-Barr Virus Mutations and Natural Genome Sequence Variations Contribute to Disease?Semantic proximity Read ↗

Quantitative analysis of Epstein-Barr virus (EBV)-related gene expression in patients with chronic active EBV infectionSemantic proximity Read ↗

Plasma Viral MicroRNA Profiles Reveal Potential Biomarkers for Chronic Active Epstein–Barr Virus InfectionSemantic proximity Read ↗

Genome-Wide Analysis of Wild-Type Epstein–Barr Virus Genomes Derived from Healthy Individuals of the 1000 Genomes ProjectSemantic proximity Read ↗

Multiomics analysis reveals the genetic and epigenetic features of high-risk NK cell–type chronic active EBV infectionSemantic proximity Read ↗

Comparative analysis of 22 Epstein-Barr virus genomes from diseased and healthy individuals.Semantic proximity Read ↗

Clinical features and whole-genome snp association study of chronic active Epstein-Barr virus infection in adults.Semantic proximity Read ↗

Epstein-Barr virus (EBV) reactivation and therapeutic inhibitorsSemantic proximity Read ↗

Epstein-Barr virus encoded EBER RNAsSemantic proximity Read ↗

Evidence of latent-lytic replication in EBV-positive Burkitt lymphoma from whole genome and transcriptome sequencingSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.